Abstract

Stem Cells In Drug Discovery – Progress and Challenges

Devyn Smith, Head of Business Operations and Strategy, Medicinal Sciences Division, Pfizer

Stem cells and related technology have been maturing, but when and how will these technologies enable drug discovery? What are some early opportunities for benefits?